Creative Planning’s Perspective Therapeutics CATX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$144K Buy
41,977
+1,747
+4% +$6.01K ﹤0.01% 3329
2025
Q1
$85.7K Sell
40,230
-30
-0.1% -$64 ﹤0.01% 3258
2024
Q4
$128K Sell
40,260
-915
-2% -$2.92K ﹤0.01% 3091
2024
Q3
$550K Buy
41,175
+23,655
+135% +$316K ﹤0.01% 2012
2024
Q2
$175K Sell
17,520
-830
-5% -$8.28K ﹤0.01% 2701
2024
Q1
$218K Buy
18,350
+4,500
+32% +$53.6K ﹤0.01% 2498
2023
Q4
$55.7K Buy
13,850
+900
+7% +$3.62K ﹤0.01% 2622
2023
Q3
$35.4K Sell
12,950
-500
-4% -$1.37K ﹤0.01% 2504
2023
Q2
$89.8K Buy
13,450
+500
+4% +$3.34K ﹤0.01% 2347
2023
Q1
$82.6K Hold
12,950
﹤0.01% 2266
2022
Q4
$32K Hold
12,950
﹤0.01% 2261
2022
Q3
$30K Hold
12,950
﹤0.01% 2127
2022
Q2
$40K Hold
12,950
﹤0.01% 2058
2022
Q1
$47K Buy
12,950
+1,500
+13% +$5.44K ﹤0.01% 2057
2021
Q4
$44K Hold
11,450
﹤0.01% 2005
2021
Q3
$72K Hold
11,450
﹤0.01% 1965
2021
Q2
$91K Sell
11,450
-10
-0.1% -$79 ﹤0.01% 1868
2021
Q1
$125K Buy
11,460
+1,381
+14% +$15.1K ﹤0.01% 2151
2020
Q4
$45K Hold
10,079
﹤0.01% 2036
2020
Q3
$59K Buy
10,079
+7,879
+358% +$46.1K ﹤0.01% 1843
2020
Q2
$12K Hold
2,200
﹤0.01% 1797
2020
Q1
$12K Buy
+2,200
New +$12K ﹤0.01% 1698
2015
Q4
Sell
-4,000
Closed -$56K 4272
2015
Q3
$56K Sell
4,000
-598
-13% -$8.37K ﹤0.01% 1948
2015
Q2
$68K Buy
4,598
+4,250
+1,221% +$62.9K ﹤0.01% 987
2015
Q1
$5K Buy
+348
New +$5K ﹤0.01% 3449